tiprankstipranks
Blueprint Medicines (BPMC)
NASDAQ:BPMC

Blueprint Medicines (BPMC) Similar Stocks

Compare
562 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Blueprint Medicines
$88.72
$5.67B
-1.06%
14 Buy
4 Hold
0 Sell
Strong Buy
Exelixis
$36.70
$10.27B
20.71
55.44%
10 Buy
7 Hold
0 Sell
Moderate Buy
FibroGen
$0.31
$31.67M
-87.17%
1 Buy
1 Hold
0 Sell
Moderate Buy
Kura Oncology
$7.05
$569.32M
-66.95%
12 Buy
3 Hold
0 Sell
Strong Buy
Argenx Se
$589.15
$36.51B
42.41
48.19%
19 Buy
2 Hold
1 Sell
Strong Buy
Terns Pharmaceuticals
$2.92
$254.91M
-52.60%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BPMC
Blueprint Medicines
88.72
-7.70
-7.99%
EXEL
Exelixis
36.70
13.02
54.98%
FGEN
FibroGen
0.31
-2.05
-86.86%
KURA
Kura Oncology
7.05
-14.77
-67.69%
ARGX
Argenx Se
589.15
191.82
48.28%
TERN
Terns Pharmaceuticals
2.92
-4.18
-58.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis